Investors.

CSE: MOOD | FSE: VU7 | OTC: DOSEF

Doseology Sciences Inc. is building a progressive brand focused on mental health and wellness through innovative functional mushroom supplements.

Corporate Team

Shawn Balaghi

INTERIM CEO, CFO
DIRECTOR

Shawn brings over 20 years of experience in the capital markets industry globally, holding key roles in finance, corporate development, and strategic planning. Previously, he has served as the CEO and CFO for several publicly listed companies and has worked closely with some of the largest independent auditing firms in Canada and the US.

Scott Reeves

DIRECTOR,
CORPORATE COUNSEL

Scott has 20+ years focused on securities, corporate finance, M&A and commercial transactions. In addition to serving on several TSX and TSX Venture exchange across multiple industries, Scott is also a partner at Tingle Merrett LLP in Calgary. He is Past Chairman and Member of the Canadian Bar Association, Calgary Bar and Law Society of Alberta.

Daniel Vice

DIRECTOR


Daniel brings advanced knowledge in pharmacotherapeutics, neuroscience, and psychiatry to Doseology. He is passionate about an integrative approach to mental health, including evidence-based treatments with the goal of achieving the best health outcomes for individuals. He received his Master's degree in nursing from Johns Hopkins University and is a psychiatric nurse practitioner doctoral student at the University of Missouri.

regulatory filings

Corporate Directory

DOSEOLOGY FACILITY

Legal Counsel
Tingle Merrett LLP.
www.tinglemerrett.com

Auditor
Dale Matheson Carr-Hilton Labonte LLP
www.dmcl.ca

Transfer Agent
Endeavor Trust Corporation
www.endeavourtrust.com